1. Experimental Section:
Chemistry

General methods
All reactions were carried out under an inert atmosphere with dry solvents, unless otherwise stated.
Reactions were monitored by thin layer chromatography (TLC) on silica gel plates (60 F254), using UV light detection. Visualization of the spots on TLC plates was achieved either by UV light or by staining the plates in 2, 4 Di-Nitro Phenylhydrazine stain, Ninhydrin stain, KMNO 4 stain and charring on hot plate. Flash chromatography was performed on silica gel (230-400 mesh) using distilled hexane, ethyl acetate, dichloromethane.
1 H NMR and 13 C NMR spectra were recorded in FTIR spectra were recorded on Bruker (Alpha) spectrometer. Mass spectra were recorded on Micro
Mass VG-7070H mass spectrometer for ESI and are given in mass units (m/z). High resolution mass spectra (HRMS) [ESI+] were obtained using either a TOF or a double focusing spectrometer.
The compounds 1a, 1b, 1c were commercially available. The methionine ester (1d) was synthesized from methionine and 7 was prepared from thiourea using literature protocols in quantitative yield. HBTU (1.5 mmol) was added to a mixture of benzoic acid (1a, 1b, 1c) (1 mmol), methionine methylester hydrochloride (1.2 mmol) in dry DCM (10 mL) at 0 °C. The reaction mixture was stirred for 1 h to which dry triethylamine (10.0 mmol) was added drop wise at 0 °C. Stirring was continued at room temperature for another 12 h. The reaction mixture was cooled in an ice bath and acidified with 2N HCl. The residue was dissolved in ethyl acetate (750 mL), washed with water (2 x 250 mL), brine (1 x 100 mL), dried over Na 2 SO 4 , filtered and the solvent evaporated.
General procedure for synthesis of 2a-c:
The residue was purified by flash chromatography (n-hexane/ ethylacetate 4:1) to afford the desired products (2a, 2b, 2c). 
(S)-Methyl 4-(methylthio)-2-(3-nitrobenzamido) butanoate (2a):
(S)-Methyl 2-(2-chloro-5-nitrobenzamido)-4-(methylthio) butanoate (2b):
The title compound was prepared in 80% yield according to the general procedure as described To a solution of (S)-4-(methylthio)-2-(3-nitrobenzamido)butanoic acid 3a (4.9 mmol) in acetic anhydride (30.4 mmol, 3 mL) was added pyridine (58.8 mmol, 5 mL) and the mixture was heated at 90 °C for 2 h. After completion the reaction mixture was concentrated to remove the excess of acidic anhydride and pyridine and the residue was extracted with EtOAc (150 mL).
The EtOAc layer was washed successively with 1.0 N HCl (50 mL), water (50 mL) and brine, dried over anhydrous Na 2 SO 4, filtered and concentrated. The residue was purified by column chromatography (EtOAc/hexanes) to provide of the desired product 4a. 
(S)-2-Chloro-N-(1-(methylthio)-4-oxopentan-3-yl)-5-nitrobenzamide (4b):
The title compound was synthesized as a yellow semi solid in 78% yield according to the general procedure described above for 4a; R f = 0.65 (30% EtOAc-n-Hexane); IR (cm -1 ): 3200, 3050, 2976, 2862, 1710 (C=O of ketone), 1655 (C=O of amide), 1518, 1323; 
(S)-N-(1-(Methylthio)-4-oxopentan-3-yl)-3,5-dinitrobenzamide (4c):
The title compound was synthesized as colorless semi solid in 74% yield according to the general procedure as described above for 4a; R f = 0.7 (30% EtOAc-n-Hexane); IR (cm and extracted with EtOAc. The combined organic phases were washed with water and brine (15 mL), dried over anhydrous Na 2 SO 4, filtered and the solvent evaporated. The residue was purified by column chromatography (EtOAc/hexanes) to provide of the desired products. 
5-Methyl-4-(2-(methylthio) ethyl)-2-(3-nitrophenyl) oxazole (5a):
2-(2-Chloro-5-nitrophenyl)-5-methyl-4-(2-(methylthio) ethyl) oxazole (5b):
The title compound was synthesized as brown color semi solid in 80% yield according to the general procedure as described above for 5a; R f = 0.7 (30% EtOAc-n-Hexane); IR (cm 
2-(3, 5-Dinitrophenyl)-5-methyl-4-(2-(methylthio) ethyl) oxazole (5c):
The title compound was synthesized as brown color semi solid in 88% yield according to the general procedure as described above for 5a; R f = 0.72 (30% EtOAc-n-Hexane); IR (cm General procedure for synthesis of 6a-c:
To a solution of 5-Methyl-4-(2-(methylthio) ethyl)-2-(3-nitrophenyl) oxazole (5a) (2.5 mmol) in 36% HCl (6 mL), stannouschloride monohydrate (12.5 mmol) was added. The mixture was heated to 100 °C for 15min, cooled to 0 O C the aqueous solution was basified with 2N NaOH and extracted three times with dichloromethane. The organic layers were combined, washed with brine solution and dried over anhydrous Na 2 SO 4 and concentrated to give desired product 6a. 
3-(5-Methyl-4-(2-(methylthio) ethyl) oxazol-2-yl) aniline (6a):
NH 2 N O S Brown solid; R f = 0.4 (30% EtOAc-n-
4-Chloro-3-(5-methyl-4-(2-(methylthio) ethyl) oxazol-2-yl) aniline (6b):
The title compound was synthesized as yellow color semi solid in 76% yield according to the general procedure as described above for 6a; R f = 0.42 (30% EtOAc-n-Hexane); IR (cm -1 ): 3400, 3375 The title compound was synthesized as colorless solid in 72% yield according to the general procedure as described above for 8a; R f = 0.8 (30% EtOAc-n-Hexane); mp 310-312 °C trifluoroacetate salt. This salt was redissolved in 20 mL of an aqueous solution of NaHCO 3 and washed with DCM (3 × 15 mL). The organic layer was washed with water (2 × 10 mL), followed by brine wash, dried over anhydrous Na 2 SO 4 and concentrated to give the corresponding free guanidine (9a). 
1-(3-(5-Methyl-4-(2-(methylthio) ethyl) oxazol-2-yl) phenyl) guanidine (9a):
1-(4-Chloro-3-(5-methyl-4-(2-(methylthio) ethyl) oxazol-2-yl) phenyl) guanidine (9b):
The title compound was synthesized as colorless semi solid in 80% yield according to the general procedure as described above for 9a; R f = 0.3 (5% MeOH-CH 2 HCl. The residue was dissolved in dichloromethane (50 mL), washed with water (2 x 250 mL), brine (1 x 100 mL), dried over Na 2 SO 4 , filtered and the solvent evaporated. The residue was purified by flash chromatography (n-hexane/ ethylacetate 4:1) to afford the desired product (10) as yellow colour semi solid in 90% yield; R f = 0.42 (30% EtOAc-n-Hexane); IR (cm 
1,1'-(5-(5-Methyl-4-(2-(methylthio) ethyl) oxazol-2-yl)-1,3-phenylene)diguanidine (9c):
N-(4-Chloro-3-(5-methyl-4-(2-(methyl thio) ethyl) oxazol-2-yl)phenyl)benzamide (11):
The title compound was synthesized as colourless semi solid in 86% yield according to the procedure as described above for 10 ( instead of acetyl chloride benzoyl chloride was taken); R f = 0.42 (10% N-(4-Chloro-3-(5-methyl-4-(2-(methylthio)ethyl)oxazol-2-yl) Methyl iodide (6.0 mmol) was added to a mixture of 4-chloro-3-(5-methyl-4-(2-(methylthio) ethyl) oxazol-2-yl) aniline (6b) (1 mmol), anhydrous K 2 CO 3 (6.0 mmol) in dry dimethyl form amide (10 mL) at 0 °C. The reaction mixture was stirred for 12 hr followed by drop wise addition of 1N HCl at 0 °C. The residue was dissolved in dichloromethane (2 x 50 mL), washed with water (2 x 150 mL), brine (1 x 50 mL), dried over Na 2 SO 4 , filtered and the solvent evaporated. The residue was purified by flash chromatography (n-hexane/ ethylacetate 3:2) to afford the desired product (14) as brown colour semi solid in 65% yield; R f = 0.20 (40% EtOAc-n-Hexane); IR (cm - 
N-(4-Chloro-3-(5-methyl-4-(2-(methylthio)ethyl)oxazol-2-yl)phenyl)methanesulfonamide (12):
1 ): 3050, 2972, 2872, 1630, 1290; 1 H NMR (300 MHz, CDCl 3 ) δ 2.14 (s, 3H), 2.45 (s, 3H), 3.05-3.16 (m, 4H), 3.55 (s, 6H), 6.82 (d, J= 8.4 Hz, 1H), 6.96 (d, J= 7.8 Hz
Pharmacology
Evaluation of cell viability
The MTT assay was used for evaluating the effect of the compounds on cell viability. RPMI medium supplemented with 10% FBS and antibiotics was used to culture HeLa and MDA-MB-231 cells. MTT dye prepared in 1X PBS was used for cell viability assays. HeLa and MDA-MB-231 cells in monolayer were trypsinised and the cell count was adjusted to 3x10 6 cells/ml using medium containing 10% fetal calf serum. Cells were pre-incubated at a concentration of 1×10 6 cells/ml in culture medium for 3h at 37°C and 6.5% CO 2 . Cells were then seeded at a concentration of 5×10 4 cells/well in 100 μl culture medium and the plates incubated at 37ºC in 5% CO 2 incubator for 24 h. After 24h, 100 μl of previously diluted compounds of different concentrations of test compounds in media were added and incubated at 37 ºC in 5% CO 2 for 72 h and cells were periodically checked for granularity, shrinkage and swelling. After 72 h, 10 ml of MTT dye was added to each well. The plates were gently shaken and incubated for 4h at 37 o C in 5% CO 2 . The supernatant was removed and 100 μl of 1:1 DMSO: Ethanol was added and the plates were gently shaken to solubilize the formed formazan. The absorbance was measured using a microplate reader at a wavelength of 550 nm. The data was plotted with log (compound concentration) on the x-axis and % viability of cells on the y-axis. Figure S6 : Log Concentration Vs % Initial aactivity for compounds 6a, 6b and 9a against LSD1
Evaluation of in vivo apoptosis and toxicity using zebrafish embryos
All procedures using zebrafish were in accordance with ethical guidelines for animal use and followed those published by the NIH. An indigenous wild type adult zebrafish strain from India was used for this study (obtained from Vikrant Aquaculture, Mumbai, India). They were maintained in a recirculation system using purified ELIX System (Millipore, Billerica, US) grade water containing 200 mg/l sea salt at 28 ºC under a 14:10 h light and dark cycle. Fish were fed three times daily with a combination of freshly hatched live brine shrimp and dry food.
Males and females were kept in separate tanks for four days before they were allowed to spawn.
On day five, 300-400 embryos were obtained by natural mating of both adult sexes (3:2 female and male ratios) in a breeding tank setup. Embryos were collected and raised in 60 mm Petri dishes containing E3 medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl 2 , and 0.33 mM MgSO 4 ) for 24 h. Compound stocks were diluted in E3 medium to obtain final concentrations of 10 μM in 0.1% DMSO. Zebrafish embryos at 24 h post fertilization were dechorionated with 500 µg/ml Pronase K for 10 minutes. Six embryos per well were placed in 24-well plates containing E3 medium and compounds added to a final concentration of 10µM (in 0.1% DMSO). The embryos were grown in the presence of the compounds for 24 h, 48 h and 72 h.
Control embryos were incubated in 0.1% DMSO. Apoptosis was assessed at the respective time points using acridine orange staining. Briefly, embryos were washed twice with 1X PBS (phosphate buffer saline) for 5min each, followed by incubation in acridine orange solution (5µg/ml in E3 medium) for 1h at room temperature. Embryos were then washed with 1X PBS three times for 5min each and visualized under an upright fluorescence microscope (Zeiss Axioscope) at an excitation wavelength of 502 nm and an emission wavelength of 525 nm.
Acridine orange is a fluorescent dye that binds to DNA and exhibits increased fluorescence in fragmented nuclei, a hallmark of apoptosis [1] [2] . Embryos were also observed using visible light microscopy at regular intervals after compound treatment to document general toxicity-related effects such as developmental delays, deformations, edema and death.
Molecular Modeling Studies
Docking method
We carried out Molecular modeling (Docking analysis and Molecular dynamics simulations) studies to reveals the binding mode and ligand receptor complex stability. The docking studies of most potent molecules were performed using the Schrodinger software suite (Maestro, version 9.2, Schrodinger, LLC: New York, NY 2012). The compounds were sketched in 3D format using build panel and were prepared for docking using ligprep application. The Protein (PDB ID: 2Z3Y) [1] [2] for docking study was retrieved from protein data bank (PDB). Figure S8: Binding orientation and interactions of 6b at the LSD1inhibitors binding site.
Molecular Dynamics Simulations Protocols:
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Molecular dynamics (MD) simulations of 9a at the binding site of protein were performed using the Desmond package incorporated in the Maestro [3] . The system was built by applying OPLS-AA force field in an explicit solvent with the single point charges (SPC) water model (OPLS-AA/SPC). The initial coordinates for the MD calculations were taken from the docking experiments. The SPC water molecules were then added and system was neutralized by adding Na+ counter-ion to balance the net charges of the system. After the construction of the solvent environment, the complex system was composed of approximately 126117 atoms. Before equilibration and long production MD simulations, the systems were minimized and preequilibrated using the default relaxation routine implemented in Desmond.
The MD simulations were run for 5 ns and during the MD simulations, the equations of motion were integrated with a 2 fs time step in the NVT ensemble. The SHAKE algorithm was applied to all hydrogen atoms; the van der Waals (VDW) cutoff was set to 9 A o . The temperature was maintained at 300 K, employing the Nosé-Hoover thermostat method with a relaxation time of 1ps. The trajectory recording interval was kept for every 10 ps during entire MD runs.
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